Brain-derived neurotrophic factor (BDNF) is an important nerve growth factor linked with development and neural plasticity. The Val66Met polymorphism in the *BDNF* gene has been associated with a significant impact on episodic memory in adults. Azeredo et al.[@B01] investigated effects of the *BDNF* Val66Met polymorphism on memory performance. Their conclusion was that, in a sample of elderly adults, *BDNF* Met allele carriers had impaired episodic memory performance as compared to Val/Val homozygotes.[@B01] However, conflicting evidence to this report exists, and the correlation between memory and Met allele carrier status is quite complex. One previous report focusing on older adults suggested that the *BDNF* Met allele is associated with higher memory performance,[@B02] whereas other studies found no effect of *BDNF* Val66Met variant on memory in older[@B03] or young adults.[@B04] It is important to note that the effects of the Val66Met polymorphism are due to modification of BDNF synthesis. Azeredo et al. measured *BDNF* genotype, but not BDNF concentrations. Interestingly, Val66Met polymorphism has been shown to be associated with increased BDNF levels by Zhang et al.,[@B05] vs. the BDNF reduction presumed by Azeredo et al., where aging-related memory decline is possibly explained by reduced neurotrophin synthesis. Another limitation of this study was the failure to exclude psychiatric patients.[@B01] The BDNF increase noted in the study by Zhang et al. was demonstrated in patients with posttraumatic stress disorder, a condition known to have significant impact on memory.

In conclusion, we believe further research into the impact of *BDNF* genotype on memory should include measurement of BDNF levels as well as psychiatric screening for conditions likely to impact memory function.
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